https://rodman.bluematrix.com/docs/pdf/b6f270cd-08a3-402b-9593-4387f7680...

Renhuang Pharmaceuticals (AMEX: CBP, Not Rated) Received Patent for Package Design for Compound Honeysuckle Granules

QRxPharma (ASX: QRX, Note Rated) Received Frost & Sullivan Award for Innovative Pain Relief Product MoxDuo

Jiangbo Pharmaceuticals (NASDAQ: JGBO, Not Rated) Launched Felodipine Sustained Release Tablets

Simcere Pharmaceutical Group (NYSE: SCR, Not Rated) Received SFDA Approval for Palonosetron

NeoStem (AMEX: NBS, Not Rated) Collaborated with the Schepens Eye Research Institute to Study VSELâ„¢ Technology

Sinobiopharma (OTC: SNBP, Not Rated) Signed Agreement to Co-Develop, Manufacture and Promote Eplerenone

Weikang Bio-Technology (OTC: WKBT, Not Rated) Announced Plans to Launch New Therapeutics in 4Q10

Ministry of Health of China Released Guidance to Treat Autism